Osteopenia (Disorder) Completed Phase 3 Trials for Nitroglycerin (DB00727)

Also known as: Osteopenia / Osteopenia (morphologic abnormality) / Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0087613 (Osteopenia (Disorder))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00043719Nitroglycerin Ointment for Preventing Bone Loss in Postmenopausal WomenPrevention